MicrobiologybioRxivPreprint
Computational Drug Repurposing Targeting LuxS-Mediated Quorum Sensing in Fusobacterium nucleatum: A Virtual Screening and Molecular Dynamics Approach
Kenneth Cedeno, Dolly De Leon, Moises Chiari
This study identifies FDA-approved drugs that inhibit LuxS in Fusobacterium nucleatum using virtual screening and molecular dynamics, offering potential anti-quorum sensing agents for CRC treatment.
DOI 10.64898/2026.04.20.719701